Japan s MediBic Alliance Takes 10 Percent Stake in Strand Genomics | GenomeWeb

NEW YORK, Sept. 16 (GenomeWeb News) -- MediBic Alliance, the investment arm of Japanese company MediBic, has acquired a 10 percent stake in Strand Genomics of Bangalore, according to news reports in India.

Financial details of the deal, which was reported on Sify.com, an India-based financial web portal, were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.